KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
13.21
-0.42 (-3.08%)
At close: Aug 1, 2025, 4:00 PM
13.75
+0.54 (4.09%)
After-hours: Aug 1, 2025, 7:46 PM EDT
Bally's Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $657.36 million as of August 1, 2025. Its market cap has increased by 0.87% in one year.
Market Cap
657.36M
Enterprise Value
548.93M
1-Year Change
0.87%
Ranking
Category
Stock Price
$13.21
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $657.36M, an increase of 408.40%. That is a compound annual growth rate of 17.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 680.90M | 62.66% |
Dec 31, 2024 | 418.60M | -1.11% |
Dec 29, 2023 | 423.30M | 154.39% |
Dec 30, 2022 | 166.40M | -48.59% |
Dec 31, 2021 | 323.70M | -4.99% |
Dec 31, 2020 | 340.70M | 7.27% |
Dec 31, 2019 | 317.60M | -6.64% |
Dec 31, 2018 | 340.20M | 223.69% |
Dec 29, 2017 | 105.10M | 690.23% |
Dec 30, 2016 | 13.30M | -86.04% |
Dec 31, 2015 | 95.30M | -26.30% |
Apr 9, 2015 | 129.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 684.37B |
Johnson & Johnson | 402.99B |
AbbVie | 344.84B |
AstraZeneca | 228.08B |
Novartis AG | 224.47B |
Abbott Laboratories | 221.54B |
UnitedHealth Group | 215.69B |
Novo Nordisk | 211.90B |